New test diagnoses brain tumours in hours, not weeks
The Guardian - 21-May-2025It may help patients start treatment earlier or join clinical trials
Join the club for FREE to access the whole archive and other member benefits.
It may help patients start treatment earlier or join clinical trials
Extra imaging boosts cancer detection where mammograms fall short, study suggests
New test detects therapy success in weeks using tumour DNA fragments in the blood
The study shows potential for precision medicine applications
AI offers a snapshot of biological age to guide medical care
Annual screening could halve late-stage cancers and cut deaths by 21% in five years
A new liquid biopsy developed at Johns Hopkins uses machine learning to spot brain tumours
Experts urge caution over routine scans due to long-term radiation risks
This age-linked surge may help detect cancer early
The robot takes detailed 3D scans without needing surgery
AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
DNase I improved CAR T cell impact and survival in a melanoma model
Understanding these mechanisms could help cancer research in humans
A major study finds plant-based oils may help reduce the risk of early death
With nearly $880 million in cash, Bicycle Therapeutics advances innovative cancer therapies
Doctors warn that treatment disparities across hospitals are putting patients’ lives at risk
Harnessing NHS data to accelerate diagnosis and drug discovery
A groundbreaking procedure at The Royal Marsden restores tissue using precision robotics
TC BioPharm’s Phase 2B trial shows TCB008 is safe with promising early effects in AML
Experts urge action as air pollution causes 1,100 lung cancer cases yearly
Scientists test drugs that clear “zombie cells” to slow ageing and improve health
Uncovering the hidden link between dirty air and deadly disease
AI-powered screenings could transform breast cancer diagnosis in the UK
Exploring the links between ageing, biomarkers, and cancer prevention
Rising diagnoses spark debate over national testing and healthcare inequalities